Devinsu Trading Appoints Independent Director, CFO, and Company Secretary

3 min read     Updated on 18 May 2026, 11:14 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Devinsu Trading Limited held a board meeting on May 18, 2026, approving the appointment of Mrs. Sangita Hiren Shukla as Additional Independent Director for five years, Mr. Krish Piyush Shah as CFO, and Ms. Khushi Gangwani as Company Secretary & Compliance Officer. The board also appointed Mr. Bhaveshkumar Arjunkumar Rawal as Secretarial Auditor and Mr. Akash Mehta as Internal Auditor, both for FY 2025-26 to FY 2029-30. The company subsequently disclosed its updated KMP structure to the stock exchange under Regulation 30(5) of SEBI (LODR) Regulations, 2015.

powered bylight_fuzz_icon
40670838

*this image is generated using AI for illustrative purposes only.

Devinsu Trading Limited convened its board meeting on May 18, 2026, to discuss and approve several key appointments. The meeting was held at the company's registered office at 2, Floor-1, Plot-90/94, Zaveri Mansion, Shaikh Memon Street, Zaveri Bazar, Kalbadevi, Mumbai – 400002, commencing at 5:30 p.m. and concluding at 7:15 p.m. The decisions taken at the meeting are aimed at strengthening the company's governance, compliance, and financial oversight framework, as disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Following the appointments, the company also notified the stock exchange of its updated Key Managerial Personnel (KMP) structure pursuant to Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Appointments

The board approved the appointment of Mrs. Sangita Hiren Shukla (DIN: 11647378) as an Additional Independent Director for a period of five years, effective from May 18, 2026 to May 17, 2031, subject to the approval of members at the ensuing Annual General Meeting. Mrs. Shukla is a highly experienced academician and administrator with over 20 years of professional experience in pharmaceutical education, institutional management, and research. She holds a Ph.D. in Pharmaceutical Sciences from Sardar Patel University, an MBA in Human Resource Management, and a Master's degree in Pharmacy (Herbal Drug Technology). She is currently serving as Principal of Indubhai Patel College of Pharmacy & Research Centre and has previously held leadership roles at reputed institutions, ensuring compliance with regulatory authorities such as AICTE, PCI, and GTU. She has over 20 publications to her credit and is not related to any director of the company, nor is she debarred from holding the office of Director by virtue of any SEBI order.

The board also appointed Mr. Krish Piyush Shah as Chief Financial Officer (CFO) effective May 18, 2026. Mr. Shah is a CFA Level III cleared finance professional with two years of hands-on experience in equity derivatives and financial market analysis, with familiarity in private markets. He is skilled in translating market data into actionable investment insights using quantitative and qualitative methods, with a strong foundation in equity valuation, risk management, alternative investments, and portfolio analysis.

Compliance and Audit Roles

To bolster its compliance functions, the company appointed Ms. Khushi Gangwani (ACS: 80518) as Company Secretary and Compliance Officer effective May 18, 2026. Ms. Gangwani is a qualified Company Secretary with over two years of professional experience, with hands-on expertise in matters relating to the Insolvency and Bankruptcy Code, 2016 (IBC), including Corporate Insolvency Resolution Process (CIRP), liquidation proceedings, and personal guarantor cases. She has worked extensively on high-value assignments and listed entity engagements, handling compliance, stakeholder coordination, regulatory filings, and NCLT-related processes.

The board further appointed Mr. Bhaveshkumar Arjunkumar Rawal (FCS: 8812; CP No. 10257), a Practicing Company Secretary, as Secretarial Auditor for a term of five consecutive years commencing from FY 2025-26 to FY 2029-30. Mr. Akash Mehta (Membership No. 168508), a Practicing Chartered Accountant with over 11 years of professional experience in statutory audit, tax advisory, GST compliance, and financial consultancy, was appointed as Internal Auditor for the same five-year term from FY 2025-26 to FY 2029-30.

Summary of Appointments

The following table summarises all key appointments approved at the board meeting:

Position: Appointee Term / Effective Date
Additional Independent Director Mrs. Sangita Hiren Shukla May 18, 2026 – May 17, 2031 (5 years)
Chief Financial Officer Mr. Krish Piyush Shah Effective May 18, 2026
Company Secretary & Compliance Officer Ms. Khushi Gangwani Effective May 18, 2026
Secretarial Auditor Mr. Bhaveshkumar Arjunkumar Rawal FY 2025-26 to FY 2029-30
Internal Auditor Mr. Akash Mehta FY 2025-26 to FY 2029-30

Updated KMP Structure

Following the appointments of Mr. Krish Piyush Shah as CFO and Ms. Khushi Gangwani as Company Secretary & Compliance Officer, the structure of the company's Key Managerial Personnel has been revised. In accordance with Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Devinsu Trading disclosed the updated KMP details to the stock exchange for the purpose of determining the materiality of events or information and for making requisite disclosures. The updated KMP structure is as follows:

Sr. No.: Name of KMP Designation
1 Mr. Deniis Desai Whole Time Director
2 Mr. Krish Piyush Shah CFO
3 Ms. Khushi Gangwani Company Secretary & Compliance Officer

The disclosure was signed by Mr. Deniis Desai, Whole Time Director (DIN: 02904192), on behalf of Devinsu Trading Limited from Mumbai. The updated KMP information has also been made available on the company's website.

Historical Stock Returns for Devinsu Trading

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%0.0%

How might Mrs. Sangita Shukla's pharmaceutical education background influence Devinsu Trading's future business strategy or potential pivot toward pharma-related ventures?

Given Ms. Khushi Gangwani's expertise in insolvency and CIRP proceedings, does this appointment signal that Devinsu Trading may be navigating or anticipating any restructuring or regulatory challenges?

Will shareholders approve Mrs. Shukla's appointment as Independent Director at the ensuing AGM, and could any opposition indicate underlying governance concerns at Devinsu Trading?

Devinsu Trading Limited Submits Q4FY26 Compliance Certificate Under SEBI Regulations

1 min read     Updated on 14 Apr 2026, 12:38 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Devinsu Trading Limited filed its Q4FY26 compliance certificate under SEBI Regulation 74(5) on April 13, 2026, covering the quarter ended March 31, 2026. The certificate was submitted to BSE Limited by Director Mukesh Kumar Bothra, with confirmation from registrar MUFG Intime India Private Limited validating proper handling of dematerialised securities and adherence to prescribed timelines.

powered bylight_fuzz_icon
37652924

*this image is generated using AI for illustrative purposes only.

Devinsu Trading Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The filing demonstrates the company's adherence to mandatory disclosure norms for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The certificate was filed on April 13, 2026, under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Director Mukesh Kumar Bothra signed and submitted the compliance document to BSE Limited on behalf of the company.

Filing Details: Information
Filing Date: April 13, 2026
Quarter Covered: Q4FY26 (ended March 31, 2026)
Regulation: SEBI Regulation 74(5)
Signatory: Mukesh Kumar Bothra, Director
DIN: 02309927

Registrar Confirmation

MUFG Intime India Private Limited (formerly Link Intime India Private Limited) issued the confirmation certificate as the company's Registrar and Share Transfer Agent. The certificate confirms compliance with dematerialisation processes during the quarter.

The registrar confirmed that:

  • Securities received from depository participants for dematerialisation were properly processed
  • All securities were confirmed (accepted/rejected) to depositories within prescribed timelines
  • Security certificates received for dematerialisation were mutilated and cancelled after due verification
  • Depository names were substituted in the register of members as registered owners

Company Information

Devinsu Trading Limited operates from its registered office at Zaveri Mansion, Kalbadevi, Mumbai. The company maintains its corporate registry through MUFG Intime India Private Limited, ensuring compliance with depositories and participants regulations.

Company Details: Information
CIN: L51900MH1985PLC036383
Scrip Code: 512445
Location: Mumbai, Maharashtra
Website: www.devinsutrading.com

The filing represents routine regulatory compliance, ensuring transparency in the company's dematerialisation processes and maintaining good standing with stock exchange requirements.

Historical Stock Returns for Devinsu Trading

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%0.0%

What strategic initiatives might Devinsu Trading pursue in FY27 following their consistent regulatory compliance track record?

How could the recent rebranding of Link Intime to MUFG Intime India impact depositories and transfer agent services for smaller listed companies?

Will SEBI introduce any new compliance requirements for trading companies in the upcoming quarters that could affect operational costs?

More News on Devinsu Trading

1 Year Returns:0.00%